Side Effects of Farxiga: What Patients Should Know
Like all medications, Farxiga comes with some possible risk of side effects. Healthcare providers are aware of these potential negative effects and will have taken them into account when issuing a prescription to a specific patient, based on their professional judgment that the benefits that the product gives to their patient outweigh the possible risk. […]
Wegovy pill vs Rybelsus: what’s the difference?
“Wegovy pill” is a term that’s gathering a lot of interest on social media platforms. It refers to a new FDA-approved oral semaglutide tablet doctors can prescribe for weight management. This gets attention because most people are aware of the tremendous changes that the introduction of GLP-1 medications such as Ozempic and Wegovy have made in […]
Is Rybelsus the same as semaglutide?
There has been a tidal wave of interest in the new “wonder drugs” that are based on chemicals called glucagon-like peptide-1 receptor agonists (GLP-1RA), which have revolutionized treatments of a wide range of potentially serious diseases. Many people are now familiar with the common terms associated with these new treatments, such as Ozempic, Mounjaro, semaglutide […]
When Blood Sugar Points to Prediabetes
Prediabetes is diagnosed when a person’s blood sugar levels are higher than normal but not high enough to be classified as diabetes. According to a 2021 study by the American Diabetes Association, 97.6 million American adults had a warning of prediabetes from a blood test. Often, it doesn’t cause noticeable symptoms, making it difficult to […]
Ozempic, Chronic Kidney Disease, and Diabetes
In January 2025, the FDA approved Ozempic (semaglutide) to help treat patients with chronic kidney disease and diabetes. Semaglutide belongs to a group of drugs called glucagon-like peptide-1 receptor agonists (GLP1-RAs), which were originally approved to help control blood sugar in people with type 2 diabetes. Other forms of GLP1-RAs include Mounjaro, Wegovy, semaglutide, and […]
New Hope for Lowering the Risk of Dementia
Just this week, I was asked by a colleague to comment on a fairly technical article, and I was struck by the exact wording used in its opening question: Are cardioprotective glucose-lowering agents associated with reduced risk of dementia? I spend a fair bit of time reviewing and replying to questions and requests from our […]
How to Understand Blood Glucose Level Results
Managing blood sugar has always been a balancing act for me, especially when I was first diagnosed with diabetes. I remember feeling overwhelmed by the readings of my blood glucose levels and thinking, “What’s ‘normal’, what’s ‘too high’, and what’s ‘too low’?” It didn’t help that the term “normal” blood sugar often seemed to refer […]
Introducing the Dawn Phenomenon
The dawn phenomenon (DP), also known as the dawn effect, refers to an observation that just over one half of people with diabetes, and nearly one-third of prediabetics, are experiencing early-morning surges in blood glucose, between 3:00 and 8:00 AM, despite not having eaten anything for several hours. This can make it harder to keep […]
The Truth: Diet and Exercise Vs. Obesity Medication
If there’s still some doubt in your mind about whether you can lose more weight with a simple diet and exercise program than you can with the highly popular new weight-loss medicines, then you should pay some attention to the following quote that puts this issue to rest once and for all. According to Dr. […]
Understanding and Managing Semaglutide Side Effects
Our friendship group contains a woman we call our very own Kim Kardashian. She knows about all the latest beauty and weight loss trends when they’re just whispers on the market and is always the first to try them. This bombshell had been talking about Ozempic for years before the shortage. Eventually, she was one […]
